Shafique Virani - Net Worth and Insider Trading
Shafique Virani Net Worth
The estimated net worth of Shafique Virani is at least $1 Million dollars as of 2024-12-29. Shafique Virani is the Chief Business Officer of Recursion Pharmaceuticals Inc and owns about 136,748 shares of Recursion Pharmaceuticals Inc (RXRX) stock worth over $1 Million. Details can be seen in Shafique Virani's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Shafique Virani has not made any transactions after 2024-01-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Shafique Virani
Shafique Virani Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Shafique Virani owns 1 companies in total, including Recursion Pharmaceuticals Inc (RXRX) .
Click here to see the complete history of Shafique Virani’s form 4 insider trades.
Insider Ownership Summary of Shafique Virani
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RXRX | Recursion Pharmaceuticals Inc | 2024-01-16 | Chief Corp. Dev. Officer |
Shafique Virani Latest Holdings Summary
Shafique Virani currently owns a total of 1 stock. Shafique Virani owns 136,748 shares of Recursion Pharmaceuticals Inc (RXRX) as of January 16, 2024, with a value of $1 Million.
Latest Holdings of Shafique Virani
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RXRX | Recursion Pharmaceuticals Inc | 2024-01-16 | 136,748 | 7.39 | 1,010,568 |
Holding Weightings of Shafique Virani
Shafique Virani Form 4 Trading Tracker
According to the SEC Form 4 filings, Shafique Virani has made a total of 17 transactions in Recursion Pharmaceuticals Inc (RXRX) over the past 5 years, including 0 buys and 17 sells. The most-recent trade in Recursion Pharmaceuticals Inc is the sale of 18,000 shares on January 16, 2024, which brought Shafique Virani around $196,740.
Insider Trading History of Shafique Virani
- 1
Shafique Virani Trading Performance
Shafique Virani Ownership Network
Shafique Virani Owned Company Details
What does Recursion Pharmaceuticals Inc do?
Who are the key executives at Recursion Pharmaceuticals Inc?
Shafique Virani is the Chief Corp. Dev. Officer of Recursion Pharmaceuticals Inc. Other key executives at Recursion Pharmaceuticals Inc include director & 10 percent owner & Chief Executive Officer Christopher Gibson , Chief Financial Officer Michael Secora , and President and COO Tina Marriott Larson .
Recursion Pharmaceuticals Inc (RXRX) Insider Trades Summary
Over the past 18 months, Shafique Virani made 8 insider transaction in Recursion Pharmaceuticals Inc (RXRX) with a net sale of 208,000. Other recent insider transactions involving Recursion Pharmaceuticals Inc (RXRX) include a net sale of 465,440 shares made by Blake Borgeson , a net sale of 1,232,842 shares made by Christopher Gibson , and a net sale of 678,124 shares made by Michael Secora .
In summary, during the past 3 months, insiders sold 231,788 shares of Recursion Pharmaceuticals Inc (RXRX) in total and bought 0 shares, with a net sale of 231,788 shares. During the past 18 months, 2,838,547 shares of Recursion Pharmaceuticals Inc (RXRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,838,547 shares.
Recursion Pharmaceuticals Inc (RXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Recursion Pharmaceuticals Inc Insider Transactions
Shafique Virani Mailing Address
Above is the net worth, insider trading, and ownership report for Shafique Virani. You might contact Shafique Virani via mailing address: C/o Recursion Pharmaceuticals, 41 S. Rio Grande Street, Salt Lake City Ut 84101.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
